Literature DB >> 8039626

nm23-H1 expression and disease recurrence after surgical resection of small hepatocellular carcinoma.

L Boix1, J Bruix, E Campo, M Sole, A Castells, J Fuster, F Rivera, A Cardesa, J Rodes.   

Abstract

BACKGROUND/AIMS: The nm23-H1 gene is thought to act as a metastasis-suppressor gene. This study investigates the relationship between nm23-H1 messenger RNA (mRNA) expression and intrahepatic tumor recurrence after surgical resection of small hepatocellular carcinoma.
METHODS: Seventeen cirrhotic patients with solitary hepatocellular carcinoma < 5 cm underwent surgical resection. In 7 patients, the neoplasm recurred after a 12-month median follow-up, whereas the other 10 patients were free of disease after a 30-month median follow-up. Both groups were similar according to age, sex, etiology, status of the underlying liver, tumor size, and other pathological characteristics of the neoplasm. nm23-H1 mRNA levels were assessed in matched tumor and surrounding cirrhotic liver samples by Northern blot hybridization using a 900-base pair probe, which is a BamHI fragment of pnm23-H1 recombinant complementary DNA clone encoding the nm23-H1 human gene.
RESULTS: Eight of the 10 patients without disease recurrence during follow-up showed nm23-H1 overexpression with an increase ranging between three- and 45-fold when compared with the nontumoral surrounding liver. Only 1 of the 7 patients with tumor recurrence showed higher nm23-H1 mRNA levels in the tumor than in the nonneoplastic sample (P = 0.013).
CONCLUSIONS: nm23 mRNA overexpression in small solitary hepatocellular carcinoma is associated with a lower recurrence rate after surgical resection, suggesting that this gene may participate in the metastatic dissemination of this neoplasm.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8039626     DOI: 10.1016/0016-5085(94)90175-9

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  7 in total

Review 1.  Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma.

Authors:  R Tung-Ping Poon; S T Fan; J Wong
Journal:  Ann Surg       Date:  2000-07       Impact factor: 12.969

2.  Immunohistochemical analysis of nm23 protein expression in malignant bone tumors.

Authors:  Y Oda; H Walter; K Radig; I Röse; W Neumann; A Roessner
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

3.  NDPKA is not just a metastasis suppressor - be aware of its metastasis-promoting role in neuroblastoma.

Authors:  Choon-Yee Tan; Christina L Chang
Journal:  Lab Invest       Date:  2017-10-09       Impact factor: 5.662

4.  Hepatocellular carcinoma and cirrhosis. Results of surgical treatment in a European series.

Authors:  J Fuster; J C García-Valdecasas; L Grande; J Tabet; J Bruix; T Anglada; P Taurá; A M Lacy; X González; R Vilana; C Bru; M Solé; J Visa
Journal:  Ann Surg       Date:  1996-03       Impact factor: 12.969

Review 5.  Nm23/NDP kinases in hepatocellular carcinoma.

Authors:  Mathieu Boissan; Marie-Lise Lacombe
Journal:  J Bioenerg Biomembr       Date:  2006-08       Impact factor: 3.853

6.  Characteristics of a thyroid carcinoma cell line derived from spinal metastasis.

Authors:  Zhenhua Zhou; Yan Li; Xu Yan; Xudong Wang; Su Chen; Jianru Xiao
Journal:  Biosci Rep       Date:  2016-12-09       Impact factor: 3.840

7.  Potential prognostic value in human breast cancer of cytosolic Nme1 protein detection using an original hen specific antibody.

Authors:  C Toulas; J Mihura; C de Balincourt; B Marques; E Marek; G Soula; H Roche; G Favre
Journal:  Br J Cancer       Date:  1996-03       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.